About Index Trending news
Analyze
Top 50 Pricing
Esperion Therapeutics

Esperion Therapeutics

Work at Esperion Therapeutics? Add yourself to this profile

Esperion Therapeutics

Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Elsewhere

Alexa global traffic share

Twitter followers

24 Mar 2015
$189,900,000
Post-IPO equity
25 Apr 2013
$33,000,000
Venture capital
01 May 2008
$22,750,000
Venture capital (Series A)